The University of Colorado Anschutz Gates Institute Achieves First-in-U.S. FDA Clearance for Campus-Built CAR T-Cell Therapy

“This work was built on the seminal findings of Craig Jordan’s laboratory, identifying CD64 as a…

Bayesian reasoning in health care: When to refuse medical tests

New AI-powered capabilities from RLDatix and real-world case studies from leading health systems address healthcare’s most…

Listen: What the Vaccine Schedule Whiplash Means for Your Kids – KFF Health News

New AI-powered capabilities from RLDatix and real-world case studies from leading health systems address healthcare’s most…

Prevention is going to overtake treatments by 2040 – Express Healthcare

MILWAUKEE, April 2, 2026 /PRNewswire/ –Agrace, the largest Wisconsin-based nonprofit hospice, has expanded to serve the…

GOP Mulls More Health Cuts – KFF Health News

The Host Recent polling finds that health costs are a top worry for much of the…

IDEAYA Biosciences Announces First-Patient-In for Phase 1 Combination Study of IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, in DLL3 Upregulated Solid Tumor Indications, including SCLC, NETs, NECs, and Melanoma

FPI achieved for first-in-class combination of IDE849 (DLL3 TOP1 ADC) and IDE161 (PARG inhibitor). IDE161 (PARG)…

RISE highlights connected data, early intervention

RISE National 2026 brought together health plan leaders, policymakers, and industry partners to examine how Medicare…

After Man’s Death Following Insurance Denials, West Virginia Tackles Prior Authorization – KFF Health News

Eric Tennant with his wife, Becky, and daughter, Amiya.(Becky Tennant) Six months after a West Virginia…

Molbio’s digital radiology arm secures CE MDR certification for its medical imaging portfolio – Express Healthcare

Molbio Diagnostics, a global diagnostics company, announced that its subsidiary, Prognosys Medical Systems, has secured the…

FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market

The U.S. Food and Drug Administration approved Eli Lilly‘s GLP-1 pill, the company said, a major…